Home
Wockhardt Ltd Board of Directors
Board of Directors at Wockhardt Ltd
Independent Director
Independent Director
Independent Director
Executive Chairman
Executive Director
Key Highlights
- H F Khorakiwala continues to serve as the Executive Chairman in 2025, maintaining the same position as in the previous year.
- Murtaza H Khorakiwala continues to serve as the Managing Director in 2025, maintaining the same position as in the previous year.
- Huzaifa H Khorakiwala continues to serve as the Executive Director in 2025, maintaining the same position as in the previous year.
- Vinesh Kumar Jairath continues to serve as the Independent Director in 2025, maintaining the same position as in the previous year.
- Zahabiya Khorakiwala joins the board as Non-Executive & Non-Independent Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Wockhardt Ltd
NSE: WOCKPHARMA
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Oct 2025 | 1291.05 |
| 29 Oct 2025 | 1306.5 |
| 28 Oct 2025 | 1295.9 |
| 27 Oct 2025 | 1293.9 |
| 24 Oct 2025 | 1330.35 |
| 23 Oct 2025 | 1358.7 |
| 21 Oct 2025 | 1372.15 |
| 20 Oct 2025 | 1340.6 |
| 17 Oct 2025 | 1344.55 |
| 16 Oct 2025 | 1357.35 |
Company Fundamentals for Wockhardt Ltd
Market Cap
20,978 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
4.8
Day’s High
1316.95
Day’s Low
1290.0
DTE
0.5
ROE
-1.1
52 Week High
1870.0
52 Week Low
1045.85
ROCE
3.7
Market Price of Wockhardt Ltd
1M
1Y
3Y
5Y
Wockhardt Ltd News Hub
Wockhardt reports consolidated net loss of Rs 14.00 crore in the June 2024 quarter
Net Loss of Wockhardt reported to Rs 14.00 crore in the quarter ended June 2024 as against net loss
Read more
09 Aug 24
Wockhardt to table results
Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered by
Read more
08 Aug 24
Wockhardt allots 8,610 equity shares under ESOS
Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotment, the pa
Read more
26 Aug 24
Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections
In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has successfully
Read more
19 Sept 24
Document
Concalls
